Apr 14, 2026
•
3 min read
Niia Essential demonstrated proof of concept, strong performance and accuracy, and zero insulin delivery failures in its first clinical study.
Apr 9, 2026
Modular Medical's two-part tubeless patch design targets "almost-pumpers," with a planned U.S. commercial launch in Q2 2026.
Apr 8, 2026
2 min read
Gravity-related pressure changes are causing incorrect insulin delivery, posing serious risks of dangerous highs and low glucose levels.
Apr 6, 2026
4 min read
The MiniMed Fit wear study is testing adhesive performance across body locations as the device moves closer to commercialization.
Apr 3, 2026
These water-activated evaporative cooling cases help keep insulin and other medications within safe temperature ranges during travel and extreme heat.
Apr 2, 2026
The new insulin reduces injections from daily to once-a-week while maintaining effective glucose control demonstrated in phase 3 clinical trials.
Apr 1, 2026
The company plans to file an IDE with the FDA in Q2 2026 following successful trials in Brazil and Australia.
Mar 31, 2026
A new reporting feature for the iLet Bionic Pancreas helps clinicians quickly identify what’s working and where diabetes management can be improved.
Mar 30, 2026
The bill caps insulin costs, forces rebate transparency, and encourages competition to lower prescription prices overall.
Mar 18, 2026
MiniMed's upcoming screenless insulin pump is controlled entirely from a phone and start going to users later this year.
Mar 17, 2026
During the conference, Dexcom showcased upcoming device updates, new platform features, and future innovations designed to expand and enhance its CGM ecosystem.
Mar 13, 2026
Approximately 1.5% of Omnipod 5 pods are impacted by a tubing issue that may cause insulin to leak inside the device.
Mar 12, 2026
The collaboration allows Accu-Chek's CGM data to flow into the Glooko platform, giving care teams a single dashboard to review glucose trends in select European markets.
Results from the EVOLUTION 2 trial presented at ATTD showed 68% time in range using a fully closed-loop system—with no mealtime boluses and minimal time below range.
Mar 11, 2026
Sequel Med Tech's insulin pump moves beyond its limited release with new integrations and wider access for users and clinicians across the United States.
Mar 10, 2026
The CE Mark allows the MiniMed 780G insulin pump to pair with the 15-day Instinct CGM expanding sensor choice for people with diabetes in Europe.
The new Liberty feature allows people with type 1 diabetes to temporarily stop counting carbs or deliver boluses while CamAPS FX automatically manages glucose levels.
Mar 5, 2026
The world's smallest tubed AID system can now be controlled from Android phones, unlocking a massive untapped market.
Mar 3, 2026
The company behind the Eversense implantable CGM is one step closer to releasing a next-gen sensor that removes the requirement for an external transmitter.
A warning letter to Unomedical raises concerns about leaking infusion sets used with insulin pumps from Medtronic, Tandem Diabetes Care, and Beta Bionics.
Feb 27, 2026
The WiFi-connected light displays real-time CGM readings using the color spectrum to help monitor high and low glucose readings for people who manage diabetes.
Feb 26, 2026
6 min read
This bedside-friendly LED display mirrors your CGM glucose data and includes optional audio alerts, a vibrating puck, and full customization via its smartphone app.
Feb 25, 2026
The MiniMed Go system combines InPen and Simplera CGM into one powerful app for people with insulin-requiring Diabetes
Feb 23, 2026
The new model is meant to lower upfront costs and expand access, joining the broader industry move toward subscription-style pump access through pharmacies.
Feb 18, 2026
The device has a customizable 7-inch display designed to display up to six CGM readings at one time making it great for people with diabetes.
